Illumina Inc. shares sank 20% after hours Thursday after the gene-sequencing company swung to a loss in the second quarter, fell short of revenue expectations and revised its full-year outlook downwar...
Tag: life sciences
Novavax slashes sales guidance in half, stock plunges 34%
Novavax Inc. executives slashed their annual sales guidance in half Monday while wildly missing financial expectations, sending shares down more than 30% in after-hours trading. Novavax NVAX, -5.01% n...
GoodRx stock rockets after earnings as company says snag with large grocer has been resolved
Shares of GoodRx Holdings Inc. were popping more than 30% in after-hours trading Monday after the company, which offers services for people looking to compare prescription drug prices, topped expectat...
What Stocks Are Moving Monday? Tesla, Palantir, First Solar and More.
Text size Tesla shares rise early Monday. (Photo by Justin Sullivan/Getty Images) Stock futures were trading higher Monday with investors assessing how aggressive the Federal Reserve will be in its ef...
Disney, Coinbase, BioNTech, Rivian, and Other Stocks to Watch This Week
Text size Second-quarter earnings season continues this week, while a pair of July inflation figures and consumer sentiment surveys will be the highlights on the economic-data calendar. On Monday, Tys...
Disney, Coinbase, BioNTech, Rivian, and Other Stocks for Investors to Watch This Week
Text size Second-quarter earnings season continues this week, while a pair of July inflation figures and consumer sentiment surveys will be the highlights on the economic-data calendar. On Monday, Tys...
Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion
Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved drug for sickle-cell disease, for about $5 billion, in the latest move by the drug giant to bolster its po...
Moderna CEO: No ‘Crazy’ Deals. We’re Giving Cash to Shareholders.
Text size Moderna CEO Stephane Bancel says his company will keep returning cash to investors until it finds a better way of creating value. Jason Alden/Bloomberg Moderna ’s CEO is feeling no pressure ...
Moderna’s Earnings Are Wednesday. Here’s What to Expect.
Text size Moderna is developing two vaccines for the fall, one for the U.S. and the other for international markets. Sean Gallup/Getty Images As the U.S. prepares for a broad Covid-19 booster campaign...
AbbVie Stock Slips After Earnings, Charge for Potential Opioid Deal
Text size AbbVie said it continues to expect adjusted diluted earnings of between $13.78 and $13.98 per share for the full fiscal year. Dreamstime The drugmaker AbbVie turned in quarterly earnings tha...
Teladoc Stock Sinks on Wider Loss and Weak Guidance
Teladoc Health was falling more than 23% in premarket trading Thursday after the remote healthcare provider posted a wider-than-expected quarterly loss after recording a $3 billion impairment charge. ...
Solar Stocks Surge After Energy Bill Gets Backing From Sen. Manchin
Text size Sen. Joe Manchin said he supported a spending package that includes funding for energy and climate programs. Andreas Rentz/Getty Images Solar stocks were surging Thursday after Sen. Joe Manc...
Semiconductor stocks have been hit hard, but many are poised for rapid growth. Here are 15 expected to shine through 2024
In December, we listed analysts’ favorite semiconductor stocks for 2022. That hasn’t turned out well. But after chipmakers’ stocks have been hammered, the group is now trading at “normal-level valuati...
The Bear Market Has Brought ‘Fear and Uncertainty’ for Gen Z. How They’re Coping.
Ella Gupta made her first investment when she was 10. With the help of her parents, she took half the profits of her bracelet-making business and invested in the stock market. At 14, she opened a Roth...
GSK Spins Off $36 Billion Consumer-Healthcare Business Haleon
GSK PLC completed the spinoff of its consumer-healthcare business, a bet that greater focus on innovative drugs and vaccines will help accelerate growth at the pharmaceuticals giant. The new stand-alo...
Opinion: Why the Inflation Reduction Act is a very big deal for Americans
NEW YORK—Senate Democrats’ compromise bill, the Inflation Reduction Act (IRA) of 2022, addresses not just inflation but also several key longstanding problems facing our economy and society. There is ...